Skip to content

Clinical trials

Hemoglobinopathies trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemoglobinopathies Country / region: United States Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20021
20041
20053
20061
20082
20093
20111
20121
20133
20142
20152
20161
20175
20182
20191
20203
20213
20228
20231
20243
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting14
Terminated10
Active, not recruiting8
Unknown status2
Enrolling by invitation2
No longer available1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vertex Pharmaceuticals Incorporated6
University of California, San Francisco5
Baylor College of Medicine4
Editas Medicine, Inc.3
Children's Hospital of Philadelphia2
Diane George2
Forma Therapeutics, Inc.2
Fred Hutchinson Cancer Center2
Masonic Cancer Center, University of Minnesota2
National Institute of Allergy and Infectious Diseases (NIAID)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemoglobinopathies58
Anemia, Sickle Cell35
Thalassemia22
Hematologic Diseases14
Bone Marrow Failure Disorders12
Immunologic Deficiency Syndromes11
beta-Thalassemia11
Genetic Diseases, Inborn10
Anemia7
Anemia, Aplastic6

Trials

Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.